Fresh analysis reveals that patients who come off blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle programs.
Findings released in a prominent health publication shows that while obese people frequently drop about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.
"Individuals purchasing these drugs need to be informed of the potential of quick rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight within about 18 months.
Comparing Approaches
The research, which reviewed dozens of studies involving over 9,000 of patients, contrasted the outcomes of these new drugs with older methods.
Researchers point out that individuals who lose weight through dieting generally experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Regain
Nutrition scientists believe the way of the jabs explains the amplified regain.
The injections mimic a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal may cause the system to produce less of its own natural hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication results in hunger is unsuppressed, making overeating a significant risk."
An Ongoing Condition?
Medical guidelines suggest the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.
Many experts argue that, considering the significant potential of weight regain, the treatment might need to be life-long.
This perspective is echoed by drug manufacturers, who note that the results "highlight the persistent nature of obesity," comparing it to managing diseases like diabetes.
Patient Testimonies
People who have come off the jabs explain a powerful resurgence of cravings.
"It was like a trigger that goes on and I was suddenly ravenous," described a patient.
This challenge is compounded if users have not developed permanent lifestyle or habit changes during therapy.
Significant Use
Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Use is more common among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than public health services.
Finally, experts emphasize that while these medications are powerful tools for shedding pounds, they are not a permanent fix and lasting health benefits relies on integrated lifestyle changes.
